Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.

Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL.

FEBS Lett. 1999 Dec 17;463(3):321-6.

2.

Review of the acetylcholinesterase inhibitor galanthamine.

Sramek JJ, Frackiewicz EJ, Cutler NR.

Expert Opin Investig Drugs. 2000 Oct;9(10):2393-402. Review.

PMID:
11060814
3.
4.

Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases.

Gulcan HO, Orhan IE, Sener B.

Curr Pharm Biotechnol. 2015;16(3):252-8. Review.

PMID:
25483718
5.
6.

Towards improved acetylcholinesterase inhibitors: a structural and computational approach.

Barril X, Orozco M, Luque FJ.

Mini Rev Med Chem. 2001 Sep;1(3):255-66. Review.

PMID:
12369972
7.
8.

A preliminary comparison of structural models for catalytic intermediates of acetylcholinesterase.

Silman I, Millard CB, Ordentlich A, Greenblatt HM, Harel M, Barak D, Shafferman A, Sussman JL.

Chem Biol Interact. 1999 May 14;119-120:43-52. Review.

PMID:
10421437
9.

An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.

Orhan IE, Orhan G, Gurkas E.

Mini Rev Med Chem. 2011 Sep;11(10):836-42. Review.

PMID:
21762104
10.
11.

Molecular modelling approaches to the design of acetylcholinesterase inhibitors: new challenges for the treatment of Alzheimer's disease.

Muñoz-Muriedas J, Lopez JM, Orozco M, Luque FJ.

Curr Pharm Des. 2004;10(25):3131-40. Review.

PMID:
15544503
12.

Galantamine in Alzheimer's disease.

Razay G, Wilcock GK.

Expert Rev Neurother. 2008 Jan;8(1):9-17. Review.

PMID:
18088197
13.
14.

An update on the pharmacology of galantamine.

Villarroya M, García AG, Marco-Contelles J, López MG.

Expert Opin Investig Drugs. 2007 Dec;16(12):1987-98. Review.

PMID:
18042006
15.

Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors.

Haviv H, Wong DM, Silman I, Sussman JL.

Curr Top Med Chem. 2007;7(4):375-87. Review.

PMID:
17305579
16.

Heterocyclic inhibitors of AChE acylation and peripheral sites.

Bolognesi ML, Andrisano V, Bartolini M, Cavalli A, Minarini A, Recanatini M, Rosini M, Tumiatti V, Melchiorre C.

Farmaco. 2005 Jun-Jul;60(6-7):465-73. Review.

PMID:
15878569
17.

Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use.

Heinrich M.

Alkaloids Chem Biol. 2010;68:157-65. Review. No abstract available.

PMID:
20334038
19.

Current status and new developments with galantamine in the treatment of Alzheimer's disease.

Tariot P.

Expert Opin Pharmacother. 2001 Dec;2(12):2027-49. Review.

PMID:
11825333
20.

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.

Drugs Aging. 2004;21(7):453-78. Review.

PMID:
15132713

Supplemental Content

Support Center